Swarajya Logo

johnson and johnson

Guillain-Barre Syndrome: FDA Issues Warning On Johnson & Johnson's Covid-19 Vaccine Linked To Rare Disorder

Bhaswati Guha Majumder
Covid-19 vaccine (Representative image)

US Decision To Not Give Emergency Authorisation To Bharat Biotech’s Covaxin Has Nothing To Do With Its Efficacy

Swarajya Staff
Covaxin Covid-19 vaccine (Pic Via Twitter)

Why Pfizer And Moderna CEOs Are Recommending Covid-19 Vaccine Boosters, And Why Some Experts Don't Agree Yet

Bhaswati Guha Majumder
Albert Bourla, Pfizer CEO. (Twitter)

Moderna And Johnson & Johnson May Participate In Yogi Govt's Global Tender To Procure 40 Million Covid Vaccine Doses

Swarajya Staff
Covid-19 vaccine. (Representative image)

US FDA Recommends Pause On Johnson & Johnson's Single Dose Vaccine Following Blood Clot Cases

Swarajya Staff
(A picture of vaccine vials from Johnson and Johnson)

All You Need To Know About Johnson & Johnson’s Covid-19 Vaccine Trial In India

Bhaswati Guha Majumder
(A picture of vaccine vials from Johnson and Johnson)

Big Pharma In Big Mess: A Crisis Of Credibility 

Rajeev Srinivasan
(Bruno Glasch/Pixabay) 

Troubles Haven’t Ended For Johnson & Johnson: Baby Shampoo Fails Watchdog’s Quality Tests  

Swarajya Staff
J&J’s baby shampoo (Photo from Johnson and Johnson website)

When Stocks Get ‘Powdered’: Johnson & Johnson In Damage-Control Mode Amid Panic-Driven $40 Billion Share Sell-Off 

Swarajya Staff
Johnson and Johnson’s baby powder. (Photo by Justin Sullivan/Getty Images)

Cancer-Causing Asbestos In Johnson & Johnson’s Baby Powder? India Set To Investigate Following Reuters Report

Swarajya Staff
Johnson’s and Johnson’s Baby Powder. (Justin Sullivan/Getty Images)

Johnson & Johnson To Pay Compensation For Faulty Implants Following Government Order

Swarajya Staff
(Photo by Justin Sullivan/Getty Images)

Get Swarajya in your inbox.